NYU Langone's AI Tool Outperforms Traditional Methods in Breast Cancer Risk Prediction — NYU Langone Health

Event summary

NYU Langone Health developed NYU-DRP, an AI model that analyzes longitudinal 3D mammograms to predict breast cancer risk more accurately than traditional methods.
The study, published on August 12, 2026, showed NYU-DRP correctly predicted higher-risk cases 72% of the time, outperforming single DBT (70%) and AI-assisted 2D testing (68%).
NYU-DRP was trained on 313,531 yearly 3D mammograms from 161,165 women without breast cancer, collected between 2016 and 2020.
The tool outperformed the Tyrer-Cuzick risk assessment, correctly predicting five-year risk 67% of the time compared to 56% for Tyrer-Cuzick.
The study found that breast density alone did not correspond to a woman's predicted risk, highlighting the tool's ability to capture additional risk factors.

The big picture

NYU Langone's AI tool represents a significant advancement in personalized breast cancer screening, leveraging longitudinal data to improve risk prediction. This development aligns with broader trends in AI-driven healthcare diagnostics, where machine learning models are increasingly used to enhance early detection and preventive care. The tool's ability to outperform traditional methods could reshape screening guidelines and reduce unnecessary tests for low-risk patients, potentially lowering healthcare costs and improving outcomes.

What we're watching

Clinical Validation: Whether NYU-DRP can sustain its predictive accuracy in larger, more diverse populations and different 3D mammogram manufacturers.
Regulatory Approval: The pace at which regulatory bodies will review and approve NYU-DRP for widespread clinical use.
Market Adoption: How quickly healthcare providers and insurers will integrate NYU-DRP into standard breast cancer screening protocols.